TY - JOUR
T1 - Complication rate after cystectomy following pelvic radiotherapy
T2 - an international, multicenter, retrospective series of 682 cases
AU - the Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology
AU - Gontero, Paolo
AU - Pisano, Francesca
AU - Palou, Joan
AU - Joniau, Steven
AU - Albersen, Maarten
AU - Colombo, Renzo
AU - Briganti, Alberto
AU - Pellucchi, Federico
AU - Faba, Oscar Rodriguez
AU - van Rhijn, Bas W.
AU - van de Putte, Elies Fransen
AU - Babjuk, Marko
AU - Fritsche, Hanz Martin
AU - Mayr, Roman
AU - Albers, Peter
AU - Niegisch, Gunter
AU - Anract, Julien
AU - Masson-Lecomte, Alexandra
AU - De la Taille, Alexandre
AU - Roupret, Morgan
AU - Peyronnet, Benoit
AU - Cai, Tomaso
AU - Witjes, Alfred J.
AU - Bruins, Max
AU - Baniel, Jack
AU - Mano, Roy
AU - Lapini, Alberto
AU - Sessa, Francesco
AU - Irani, Jaques
AU - Brausi, Maurizio
AU - Stenzl, Arnulf
AU - Karnes, Jeffrey R.
AU - Scherr, Douglas
AU - O’Malley, Padraic
AU - Taylor, Benjamin
AU - Shariat, Shahrokh F.
AU - Black, Peter
AU - Abdi, Hamidreza
AU - Matveev, Vsevolod B.
AU - Samuseva, Olga
AU - Parekh, Dipen
AU - Gonzalgo, Mark
AU - Vetterlein, Malte W.
AU - Aziz, Atiqullah
AU - Fisch, Margit
AU - Catto, James
AU - Pang, Karl H.
AU - Xylinas, Evanguelos
AU - Rink, Michael
N1 - Publisher Copyright:
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Purpose: Conflicting evidence exists on the complication rates after cystectomy following previous radiation (pRTC) with only a few available series. We aim to assess the complication rate of pRTC for abdominal–pelvic malignancies. Methods: Patients treated with radical cystectomy following any previous history of RT and with available information on complications for a minimum of 1 year were included. Univariable and multivariable logistic regression models were used to assess the relationship between the variable parameters and the risk of any complication. Results: 682 patients underwent pRTC after a previous RT (80.5% EBRT) for prostate, bladder (BC), gynecological or other cancers in 49.1%, 27.4%, 9.8% and 12.9%, respectively. Overall, 512 (75.1%) had at least one post-surgical complication, classified as Clavien ≥ 3 in 29.6% and Clavien V in 2.9%. At least one surgical complication occurred in 350 (51.3%), including bowel leakage in 6.2% and ureteric stricture in 9.4%. A medical complication was observed in 359 (52.6%) patients, with UTI/pyelonephritis being the most common (19%), followed by renal failure (12%). The majority of patients (86%) received an incontinent urinary diversion. In multivariable analysis adjusted for age, gender and type of RT, patients treated with RT for bladder cancer had a 1.7 times increased relative risk of experiencing any complication after RC compared to those with RT for prostate cancer (p = 0.023). The type of diversion (continent vs non-continent) did not influence the risk of complications. Conclusion: pRTC carries a high rate of major complications that dramatically exceeds the rates reported in RT-naïve RCs.
AB - Purpose: Conflicting evidence exists on the complication rates after cystectomy following previous radiation (pRTC) with only a few available series. We aim to assess the complication rate of pRTC for abdominal–pelvic malignancies. Methods: Patients treated with radical cystectomy following any previous history of RT and with available information on complications for a minimum of 1 year were included. Univariable and multivariable logistic regression models were used to assess the relationship between the variable parameters and the risk of any complication. Results: 682 patients underwent pRTC after a previous RT (80.5% EBRT) for prostate, bladder (BC), gynecological or other cancers in 49.1%, 27.4%, 9.8% and 12.9%, respectively. Overall, 512 (75.1%) had at least one post-surgical complication, classified as Clavien ≥ 3 in 29.6% and Clavien V in 2.9%. At least one surgical complication occurred in 350 (51.3%), including bowel leakage in 6.2% and ureteric stricture in 9.4%. A medical complication was observed in 359 (52.6%) patients, with UTI/pyelonephritis being the most common (19%), followed by renal failure (12%). The majority of patients (86%) received an incontinent urinary diversion. In multivariable analysis adjusted for age, gender and type of RT, patients treated with RT for bladder cancer had a 1.7 times increased relative risk of experiencing any complication after RC compared to those with RT for prostate cancer (p = 0.023). The type of diversion (continent vs non-continent) did not influence the risk of complications. Conclusion: pRTC carries a high rate of major complications that dramatically exceeds the rates reported in RT-naïve RCs.
KW - Bladder cancer
KW - Complications
KW - Radiation therapy
KW - Radical cystectomy
KW - Urinary diversion
UR - http://www.scopus.com/inward/record.url?scp=85074815045&partnerID=8YFLogxK
U2 - 10.1007/s00345-019-02982-6
DO - 10.1007/s00345-019-02982-6
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31691084
AN - SCOPUS:85074815045
SN - 0724-4983
VL - 38
SP - 1959
EP - 1968
JO - World Journal of Urology
JF - World Journal of Urology
IS - 8
ER -